Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice

Trial Profile

Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Nov 2017

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Unstable angina pectoris
  • Focus Therapeutic Use
  • Acronyms e-Ultimaster
  • Sponsors Terumo
  • Most Recent Events

    • 02 Nov 2017 Results (n=3205) assessing 1 year clinical outcomes from the e-Ultimaster registry in a predefined subset of high-risk patients with acute coronary syndrome presented at the 29th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
    • 07 Aug 2017 Planned number of patients changed from 17000 to 37000.
    • 09 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top